MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.
Wang S, Zhu L, Zuo W, Zeng Z, Huang L, Lin F, Lin R, Wang J, Lu J, Wang Q, Lin L, Dong H, Wu W, Zheng K, Cai J, Yang S, Ma Y, Ye S, Liu W, Yu Y, Tan J, Liu B.
Wang S, et al. Among authors: tan j.
Oncotarget. 2016 Jun 21;7(25):37693-37713. doi: 10.18632/oncotarget.9264.
Oncotarget. 2016.
PMID: 27177222
Free PMC article.